Dajin Zou
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 2%
- Surgery top 10%
- Pharmacology top 2%
- Physiology top 10%
- Co-authors
- Guang NingYifei ZhangJie HongYan GuoMiao WangChaoqian LiuZhiping HuangJialin Yang
- Topics
- Diabetes Treatment and Management (19 papers)Diabetes Management and Research (12 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Dajin Zou
62 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 889
- Endocrinology, Diabetes and Metabolism 692
- Surgery 506
- Pharmacology 448
- Physiology 346
Countries citing papers authored by Dajin Zou
This map shows the geographic impact of Dajin Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dajin Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dajin Zou more than expected).
Fields of papers citing papers by Dajin Zou
This network shows the impact of papers produced by Dajin Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dajin Zou. The network helps show where Dajin Zou may publish in the future.
Co-authorship network of co-authors of Dajin Zou
This figure shows the co-authorship network connecting the top 25 collaborators of Dajin Zou. A scholar is included among the top collaborators of Dajin Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dajin Zou. Dajin Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 136 | |
| 4 | 54 | |
| 5 | 27 | |
| 6 | 35 | |
| 7 | 5 | |
| 8 | 33 | |
| 9 | 6 | |
| 10 | 2 | |
| 11 | 184 | |
| 12 | Characterization of lipid metabolism-related genes in mouse fatty liver | 1 |
| 13 | 10 | |
| 14 | Therapeutic effects of radioisotope labeled Ku70 antisense oligodeoxynuclecotide on thyroid carcinoma implanted in nude mice | 1 |
| 15 | 6 | |
| 16 | 1 | |
| 17 | Association of Lys656Asn variant in leptin receptor gene with serum triglyceride level in obese population | 1 |
| 18 | Efficacy, safety and acceptance of Acarbose treatment under day-to-day clinical practice conditions: Post-Marketing Surveillance in Chinese type 2 diabetic patients | 3 |
| 19 | The effects of pioglitazone on oxidative stress of the kidneys of diabetic rats | 0 |
| 20 | 17 |
About Dajin Zou
Dajin Zou is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Pharmacology, having authored 63 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (19 papers), Diabetes Management and Research (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (692 citations), Pharmacology (448 citations) and Pharmacology (130 citations). Dajin Zou has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Guang Ning, Yifei Zhang, Jie Hong, Yan Guo, Miao Wang, Chaoqian Liu, Zhiping Huang, Jialin Yang, Na Zhu and Wei Liu. Their work appears in journals such as Nature Communications, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.